Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: Role of mitogen-activated protein kinases and cell cycle regulators

Steroids

Volumn 70, Issue 5-7 SPEC. ISS., 2005, Pages 418-426

  Faivre, Emily ^a   Skildum, Andy ^a   Pierson Mullany, Lisa ^a   Lange, Carol A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Breast cancer; Cell cycle progression; Cyclin D1; Cyclin dependent protein kinase; MAP Kinase; Progesterone receptor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; GESTAGEN; HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE RECEPTOR; PROTEIN P27; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE S PHASE; CELL STIMULATION; CONTROLLED STUDY; ENZYME BLOOD LEVEL; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; ONCOGENE SRC; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 18144432142     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2005.02.012     Document Type: Article

References (40)

1. A. Migliaccio, D. Piccolo, G. Castoria, M. Di Domenico, A. Bilancio, and M. Lombardi Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor EMBO J 17 7 1998 2008 2018
2. V. Boonyaratanakornkit, M.P. Scott, V. Ribon, L. Sherman, S.M. Anderson, and J.L. Maller Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases Mol Cell 8 2 2001 269 280
3. C.A. Sartorius, S.D. Groshong, A. Miller, R.L. Powell, L. Tung, and G. Takimoto New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors; only antiprogestin-occupied B-receptors are switched to transcriptional agonists by camp Cancer Res 54 1994 3868 3877
4. C.A. Lange-Carter, and G.L. Johnson Assay of MEK kinases Meth Enzymol 255 1995 290 301
5. H. Matsushime, D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.Y. Kato D-type cyclin-dependent kinase activity in mammalian cells Mol Cell Biol 14 3 1994 2066 2076
6. A. Skildum, E. Faivre, and C.A. Lange Progesterone receptors induce cell cycle progression via activation of mitogen activated protein kinases Mol Endocrinol 2004
7. M.R. Moore, J.L. Zhou, K.A. Blankenship, J.S. Strobl, D.P. Edwards, and R.N. Gentry A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene J Steroid Biochem Mol Biol 62 4 1997 243 252
8. D. Chalbos, M. Chambon, G. Ailhaud, and H. Rochefort Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells J Biol Chem 262 21 1987 9923 9926
9. S. Krusekopf, A. Chauchereau, E. Milgrom, D. Henderson, and A.C. Cato Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells J Steroid Biochem Mol Biol 40 1-3 1991 239 245
10. N.J. McKenna, R.B. Lanz, and B.W. O'Malley Nuclear receptor coregulators: cellular and molecular biology Endocrinol Rev 20 1999 321 344
11. G.I. Owen, J.K. Richer, L. Tung, G. Takimoto, and K.B. Horwitz Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300 J Biol Chem 273 17 1998 10696 10701
12. L. Cicatiello, R. Addeo, A. Sasso, L. Altucci, V.B. Petrizzi, and R. Borgo Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter Mol Cell Biol 24 16 2004 7260 7274
13. T. Shen, K.B. Horwitz, and C.A. Lange Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294 Mol Cell Biol 21 18 2001 6122 6131
14. C.A. Lange, T. Shen, and K.B. Horwitz Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome Proc Natl Acad Sci USA 97 3 2000 1032 1037
15. L.K. Pierson-Mullany, and C.A. Lange Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase2 Mol Cell Biol 24 24 2004
16. K.J. Sweeney, B. Sarcevic, R.L. Sutherland, and E.A. Musgrove Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells Oncogene 14 11 1997 1329 1340
17. S.D. Groshong, G.I. Owen, B. Grimison, I.E. Schauer, M.C. Todd, and T.A. Langan Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1) Mol Endocrinol 11 11 1997 1593 1607
18. T.A. Knotts, R.S. Orkiszewski, R.G. Cook, D.P. Edwards, and N.L. Weigel Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites J Biol Chem 276 11 2001 8475 8483
19. Y. Zhang, C.A. Beck, A. Poletti, J.Pt. Clement, P. Prendergast, and T.T. Yip Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo Mol Endocrinol 11 6 1997 823 832
20. C.A. Lange, J.K. Richer, and K.B. Horwitz Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals Mol Endocrinol 13 6 1999 829 836
21. M. Qiu, and C.A. Lange MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association J Steroid Biochem Mol Biol 85 2-5 2003 147 157
22. C.A. Lange Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Mol Endocrinol 18 2 2004 269 278
23. A.M. Bamberger, C.M. Bamberger, B. Gellersen, and H.M. Schulte Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells Proc Natl Acad Sci USA 93 12 1996 6169 6174
24. L. Murphy, T. Cherlet, A. Lewis, Y. Banu, and P. Watson New insights into estrogen receptor function in human breast cancer Ann Med 35 8 2003 614 631
25. L. Labriola, M. Salatino, C.J. Proietti, A. Pecci, O.A. Coso, and A.R. Kornblihtt Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells Mol Cell Biol 23 3 2003 1095 1111
26. C. Catzavelos, N. Bhattacharya, Y.C. Ung, J.A. Wilson, L. Roncari, and C. Sandhu Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer Nat Med 3 2 1997 227 230
27. M. Qiu, A. Olsen, E. Faivre, K.B. Horwitz, and C.A. Lange Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors Mol Endocrinol 17 4 2003 628 642
28. S.J. Moeller, E.D. Head, and R.J. Sheaff p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation Mol Cell Biol 23 11 2003 3735 3752
29. J. Lamb, S. Ramaswamy, H.L. Ford, B. Contreras, R.V. Martinez, and F.S. Kittrell A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer Cell 114 3 2003 323 334
30. R.M. Zwijsen, E. Wientjens, R. Klompmaker, J. van der Sman, R. Bernards, and R.J. Michalides CDK-independent activation of estrogen receptor by cyclin D1 Cell 88 3 1997 405 415
31. T.K. Johnson, R.E. Schweppe, J. Septer, and R.E. Lewis Phosphorylation of B-Myb regulates its transactivation potential and DNA binding J Biol Chem 274 51 1999 36741 36749
32. S. Lane, P. Farlie, and R. Watson B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation Oncogene 14 20 1997 2445 2453
33. A. Sala, M. Kundu, I. Casella, A. Engelhard, B. Calabretta, and L. Grasso Activation of human B-MYB by cyclins Proc Natl Acad Sci USA 94 2 1997 532 536
34. J.D. Bennett, P.G. Farlie, and R.J. Watson E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts Oncogene 13 5 1996 1073 1082
35. C. Robinson, Y. Light, R. Groves, D. Mann, R. Marias, and R. Watson Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle Oncogene 12 9 1996 1855 1864
36. S. Horstmann, S. Ferrari, and K.H. Klempnauer Regulation of B-Myb activity by cyclin D1 Oncogene 19 2 2000 298 306
37. Narayanan R, Adigun AA, Edwards DP, Weigel NL, Human progesterone receptor function is modulated by cyclinA/Cdk-2 and in impaired during the G2 phase of the cell cycle, Philadelphia, PA, 2003; p. 65.
38. R.T. Chlebowski, S.L. Hendrix, R.D. Langer, M.L. Stefanick, M. Gass, and D. Lane Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women JAMA 289 24 2003 3243 3253
39. V. Beral Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 9382 2003 419 427
40. C.S. Murphy, J.J. Pink, and V.C. Jordan Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions Cancer Res 50 22 1990 7285 7292